Table of Contents Author Guidelines Submit a Manuscript
Obstetrics and Gynecology International
Volume 2010, Article ID 162363, 16 pages
http://dx.doi.org/10.1155/2010/162363
Review Article

Molecular Profiling of Endometrial Malignancies

1Department of Pathology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA
2Department of Obstetrics and Gynecology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA

Received 1 October 2009; Revised 9 December 2009; Accepted 14 January 2010

Academic Editor: Paul J. Hoskins

Copyright © 2010 Norasate Samarnthai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. F. Lax, “Molecular genetic changes in epithelial, stromal and mixed neoplasms of the endometrium,” Pathology, vol. 39, no. 1, pp. 46–54, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. S. G. Silverberg, R. J. Kurman, F. Nogales, G. Mutter, R. A. Kubik-Huch, and F. A. Tavassoli, “Epithelial tumors and related lesions,” in Pathology and Genetics of Tumors of the Breast and Female Organs, P. Devilee and F. A. Tavassoli, Eds., IARC Press, Lyon, France, 2003. View at Google Scholar
  3. M. J. Horner, L. A. G. Ries, M. Krapcho et al., “SEER Cancer Statistics Review 1975–2006,” 2009, http://seer.cancer.gov/csr/1975_2006/.
  4. N. Bansal, V. Yendluri, and R. M. Wenham, “The molecular biology of endometrial cancers and the implications for pathogenesis, classification, and targeted therapies,” Cancer Control, vol. 16, no. 1, pp. 8–13, 2009. View at Google Scholar · View at Scopus
  5. J. V. Bokhman, “Two pathogenetic types of endometrial carcinoma,” Gynecologic Oncology, vol. 15, no. 1, pp. 10–17, 1983. View at Google Scholar · View at Scopus
  6. A. Di Cristofano and L. H. Ellenson, “Endometrial carcinoma,” Annual Review of Pathology, vol. 2, pp. 57–85, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. D. Llobet, J. Pallares, A. Yeramian et al., “Molecular pathology of endometrial carcinoma: practical aspects from the diagnostic and therapeutic viewpoints,” Journal of Clinical Pathology, vol. 62, no. 9, pp. 777–785, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. X. Matias-guiu, L. Catasus, E. Bussaglia et al., “Molecular pathology of endometrial hyperplasia and carcinoma,” Human Pathology, vol. 32, no. 6, pp. 569–577, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. J. Prat, A. Gallardo, M. Cuatrecasas, and L. Catasús, “Endometrial carcinoma: pathology and genetics,” Pathology, vol. 39, no. 1, pp. 72–87, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. F.-S. Liu, “Molecular carcinogenesis of endometrial cancer,” Taiwanese Journal of Obstetrics and Gynecology, vol. 46, no. 1, pp. 26–32, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. S. F. Lax, “Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification,” Virchows Archiv, vol. 444, no. 3, pp. 213–223, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. J. L. Hecht and G. L. Mutter, “Molecular and pathologic aspects of endometrial carcinogenesis,” Journal of Clinical Oncology, vol. 24, no. 29, pp. 4783–4791, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. A. Doll, M. Abal, M. Rigau et al., “Novel molecular profiles of endometrial cancer-new light through old windows,” Journal of Steroid Biochemistry and Molecular Biology, vol. 108, no. 3-5, pp. 221–229, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. S. N. Westin, R. R. Broaddus, L. Deng et al., “Molecular clustering of endometrial carcinoma based on estrogen-induced gene expression,” Cancer Biology & Therapy, vol. 8, no. 22, pp. 2126–2135, 2009. View at Google Scholar
  15. L. Catasus, A. Gallardo, M. Cuatrecasas, and J. Prat, “Concomitant PI3K-AKT and p53 alterations in endometrial carcinomas are associated with poor prognosis,” Modern Pathology, vol. 22, no. 4, pp. 522–529, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. Y. Karamurzin and J. K. L. Rutgers, “DNA mismatch repair deficiency in endometrial carcinoma,” International Journal of Gynecological Pathology, vol. 28, no. 3, pp. 239–255, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. H. Tashiro, M. S. Blazes, R. Wu et al., “Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies,” Cancer Research, vol. 57, no. 18, pp. 3935–3940, 1997. View at Google Scholar · View at Scopus
  18. M. E. Sherman, M. E. Bur, and R. J. Kurman, “p53 in endometrial cancer and its putative precursors: evidence for diverse pathways of tumorigenesis,” Human Pathology, vol. 26, no. 11, pp. 1268–1274, 1995. View at Google Scholar · View at Scopus
  19. J. Pallares, E. Bussaglia, J. L. Martínez-Guitarte et al., “Immunohistochemical analysis of PTEN in endometrial carcinoma: a tissue microarray study with a comparison of four commercial antibodies in correlation with molecular abnormalities,” Modern Pathology, vol. 18, no. 5, pp. 719–727, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. A. Velasco, E. Bussaglia, J. Pallares et al., “PIK3CA gene mutations in endometrial carcinoma. Correlation with PTEN and K-RAS alterations,” Human Pathology, vol. 37, no. 11, pp. 1465–1472, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. A. Dutt, H. B. Salvesen, H. Greulich, W. R. Sellers, R. Beroukhim, and M. Meyerson, “Somatic mutations are present in all members of the AKT family in endometrial carcinoma,” British Journal of Cancer, vol. 101, no. 7, pp. 1218–1219, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. H. Tashiro, C. Isacson, R. Levine, R. J. Kurman, K. R. Cho, and L. Hedrick, “p53 gene mutations are common in uterine serous carcinoma and occur early in their pathogenesis,” American Journal of Pathology, vol. 150, no. 1, pp. 177–185, 1997. View at Google Scholar · View at Scopus
  23. R. A. Ambros, M. E. Sherman, C. M. Zahn, P. Bitterman, and R. J. Kurman, “Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation,” Human Pathology, vol. 26, no. 11, pp. 1260–1267, 1995. View at Google Scholar · View at Scopus
  24. L. A. Meyer, R. R. Broaddus, and K. H. Lu, “Endometrial cancer and lynch syndrome: clinical and pathologic considerations,” Cancer Control, vol. 16, no. 1, pp. 14–22, 2009. View at Google Scholar · View at Scopus
  25. K. Garg and R. A. Soslow, “Lynch syndrome (hereditary non-polyposis colorectal cancer) and endometrial carcinoma,” Journal of Clinical Pathology, vol. 62, no. 8, pp. 679–684, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. T. T. Nieminen, A. Gylling, W. M. Abdel-Rahman et al., “Molecular analysis of endometrial tumorigenesis: importance of complex hyperplasia regardless of atypia,” Clinical Cancer Research, vol. 15, no. 18, pp. 5772–5783, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. R. Pilarski, “Cowden syndrome: a critical review of the clinical literature,” Journal of Genetic Counseling, vol. 18, no. 1, pp. 13–27, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. J. A. Hobert and C. Eng, “PTEN hamartoma tumor syndrome: an overview,” Genetics in Medicine, vol. 11, no. 10, pp. 687–694, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. K. M. Schmeler, M. S. Daniels, A. C. Brandt, and K. H. Lu, “Endometrial cancer in an adolescent: a possible manifestation of Cowden syndrome,” Obstetrics and Gynecology, vol. 114, no. 2, part 2, pp. 477–479, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. M. R. Nelen, W. C. G. Van Staveren, E. A. J. Peeters et al., “Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease,” Human Molecular Genetics, vol. 6, no. 8, pp. 1383–1387, 1997. View at Publisher · View at Google Scholar · View at Scopus
  31. N. E. Lynch, S. A. Lynch, J. McMenamin, and D. Webb, “Bannayan-Riley-Ruvalcaba syndrome: a cause of extreme macrocephaly and neurodevelopmental delay,” Archives of Disease in Childhood, vol. 94, no. 7, pp. 553–554, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. W. G. McCluggage, U. Haller, R. J. Kurman, and R. A. Kubik-Huch, “Mixed epithelial and mesenchymal tumors,” in Pathology and Genetics of Tumors of the Breast and Female Organs, P. Deville and F. A. Tavassoli, Eds., IARC Press, Lyon, France, 2003. View at Google Scholar
  33. W. G. McCluggage, “Malignant biphasic uterine tumours: carcinosarcomas or metaplastic carcinomas?” Journal of Clinical Pathology, vol. 55, no. 5, pp. 321–325, 2002. View at Google Scholar · View at Scopus
  34. W. G. McCluggage, “Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomas,” International Journal of Gynecological Cancer, vol. 12, no. 6, pp. 687–690, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. L. E. Kernochan and R. L. Garcia, “Carcinosarcomas (malignant mixed müllerian tumor) of the uterus: advances in elucidation of biologic and clinical characteristics,” Journal of the National Comprehensive Cancer Network, vol. 7, no. 5, pp. 550–557, 2009. View at Google Scholar · View at Scopus
  36. A. Schipf, D. Mayr, T. Kirchner, and J. Diebold, “Molecular genetic aberrations of ovarian and uterine carcinosarcomas—a CGH and FISH study,” Virchows Archiv, vol. 452, no. 3, pp. 259–268, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. H. Fujii, M. Yoshida, Z. X. Gong et al., “Frequent genetic heterogeneity in the clonal evolution of gynecological carcinosarcoma and its influence on phenotypic diversity,” Cancer Research, vol. 60, no. 1, pp. 114–120, 2000. View at Google Scholar · View at Scopus
  38. M. Saegusa, M. Hashimura, T. Kuwata, and I. Okayasu, “Requirement of the Akt/β-catenin pathway for uterine carcinosarcoma genesis, modulating E-cadherin expression through the transactivation of slug,” American Journal of Pathology, vol. 174, no. 6, pp. 2107–2115, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  39. P. Baker and E. Oliva, “Endometrial stromal tumours of the uterus: a practical approach using conventional morphology and ancillary techniques,” Journal of Clinical Pathology, vol. 60, no. 3, pp. 235–243, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. M. R. Hendrickson, F. A. Tavassoli, and R. L. Kempson, “Mesenchymal tumors and related lesion,” in Pathology and Genetics of Tumors of the Breast and Female Organs, P. Devilee and F. A. Tavassoli, Eds., IARC Press, Lyon, France, 2003. View at Google Scholar
  41. F. Moinfar, M. Azodi, and F. A. Tavassoli, “Uterine sarcomas,” Pathology, vol. 39, no. 1, pp. 55–71, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  42. A. A. Sandberg, “The cytogenetics and molecular biology of endometrial stromal sarcoma,” Cytogenetic and Genome Research, vol. 118, no. 2–4, pp. 182–189, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. B. Liegl, O. Reich, F. F. Nogales, and S. Regauer, “PDGF-α and PDGF-β are expressed in endometrial stromal sarcoma: a potential therapeutic target for tyrosine kinase inhibitors?” Histopathology, vol. 49, no. 5, pp. 545–546, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  44. M. R. Nucci, D. Harburger, J. Koontz, P. D. Cin, and J. Sklar, “Molecular analysis of the JAZF1-JJAZ1 gene fusion by RT-PCR and fluorescence in situ hybridization in endometrial stromal neoplasms,” American Journal of Surgical Pathology, vol. 31, no. 1, pp. 65–70, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  45. I. Panagopoulos, F. Mertens, and C. A. Griffin, “An endometrial stromal sarcoma cell line with the JAZF1/PHF1 chimera,” Cancer Genetics and Cytogenetics, vol. 185, no. 2, pp. 74–77, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  46. H.-Y. Huang, M. Ladanyi, and R. A. Soslow, “Molecular detection of JAZF1-JJAZ1 gene fusion in endometrial stromal neoplasms with classic and variant histology: evidence for genetic heterogeneity,” American Journal of Surgical Pathology, vol. 28, no. 2, pp. 224–232, 2004. View at Publisher · View at Google Scholar · View at Scopus
  47. F. Moinfar, M.-L. Kremser, Y. G. Man, K. Zatloukal, F. A. Tavassoli, and H. Denk, “Allelic imbalances in endometrial stromal neoplasms: frequent genetic alterations in the nontumorous normal-appearing endometrial and myometrial tissues,” Gynecologic Oncology, vol. 95, no. 3, pp. 662–671, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  48. A. Hrzenjak, F. Moinfar, F. A. Tavassoli et al., “JAZF1/JJAZ1 gene fusion in endometrial stromal sarcomas. Molecular analysis by reverse transcriptase-polymerase chain reaction optimized for paraffin-embedded tissue,” Journal of Molecular Diagnostics, vol. 7, no. 3, pp. 388–395, 2005. View at Google Scholar · View at Scopus
  49. S. Kurihara, Y. Oda, Y. Ohishi et al., “Endometrial stromal sarcomas and related high-grade sarcomas: immunohistochemical and molecular genetic study of 31 cases,” American Journal of Surgical Pathology, vol. 32, no. 8, pp. 1228–1238, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  50. F. Micci, I. Panagopoulos, B. Bjerkehagen, and S. Heim, “Consistent rearrangement of chromosomal band 6p21 with generation of fusion genes JAZF1/PHF1 and EPC1/PHF1 in endometrial stromal sarcoma,” Cancer Research, vol. 66, no. 1, pp. 107–112, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  51. F. Amant, P. Moerman, I. Cadron, A. Hagemeijer, I. Vergote, and M. Debiec-Rychter, “Endometrial stromal sarcoma with a sole t(X;17) chromosome change: report of a case and review of the literature,” Gynecologic Oncology, vol. 88, no. 3, pp. 459–462, 2003. View at Publisher · View at Google Scholar · View at Scopus
  52. K. Leunen, F. Amant, M. Debiec-Rychter et al., “Endometrial stromal sarcoma presenting as postpartum haemorrhage: report of a case with a sole t(10;17)(q22;p13) translocation,” Gynecologic Oncology, vol. 91, no. 1, pp. 265–271, 2003. View at Publisher · View at Google Scholar · View at Scopus
  53. S. Regauer, W. Emberger, O. Reich, and R. Pfragner, “Cytogenetic analyses of two new cases of endometrial stromal sarcoma—non-random reciprocal translocation t(10;17)(q22;p13) correlates with fibrous ESS,” Histopathology, vol. 52, no. 6, pp. 780–783, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  54. E. Oliva, L. De Leval, R. A. Soslow, and C. Herens, “High frequency of JAZF1-JJAZ1 gene fusion in endometrial stromal tumors with smooth muscle differentiation by interphase FISH detection,” American Journal of Surgical Pathology, vol. 31, no. 8, pp. 1277–1284, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  55. I. Halbwedl, R. Ullmann, M.-L. Kremser et al., “Chromosomal alterations in low-grade endometrial stromal sarcoma and undifferentiated endometrial sarcoma as detected by comparative genomic hybridization,” Gynecologic Oncology, vol. 97, no. 2, pp. 582–587, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  56. F. Micci and S. Heim, “Pathogenetic mechanisms in endometrial stromal sarcoma,” Cytogenetic and Genome Research, vol. 118, no. 2–4, pp. 190–195, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  57. A. Hrzenjak, M. Tippl, M.-L. Kremser et al., “Inverse correlation of secreted frizzled-related protein 4 and β-catenin expression in endometrial stromal sarcomas,” Journal of Pathology, vol. 204, no. 1, pp. 19–27, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  58. J. C. Hodge, B. J. Quade, M. A. Rubin, E. A. Stewart, P. D. Cin, and C. C. Morton, “Molecular and cytogenetic characterization of plexiform leiomyomata provide further evidence for genetic heterogeneity underlying uterine fibroids,” American Journal of Pathology, vol. 172, no. 5, pp. 1403–1410, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  59. B. Levy, T. Mukherjee, and K. Hirschhorn, “Molecular cytogenetic analysis of uterine leiomyoma and leiomyosarcoma by comparative genomic hybridization,” Cancer Genetics and Cytogenetics, vol. 121, no. 1, pp. 1–8, 2000. View at Publisher · View at Google Scholar · View at Scopus
  60. J. Yang, X. Du, K. Chen et al., “Genetic aberrations in soft tissue leiomyosarcoma,” Cancer Letters, vol. 275, no. 1, pp. 1–8, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  61. A. N. Y. Cheung, “Molecular targets in gynaecological cancers,” Pathology, vol. 39, no. 1, pp. 26–45, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  62. S. M. Temkin and G. Fleming, “Current treatment of metastatic endometrial cancer,” Cancer Control, vol. 16, no. 1, pp. 38–45, 2009. View at Google Scholar
  63. A. Gadducci, R. Tana, S. Cosio, A. Fanucchi, and A. R. Genazzani, “Molecular target therapies in endometrial cancer: from the basic research to the clinic,” Gynecological Endocrinology, vol. 24, no. 5, pp. 239–249, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  64. A. A. Kamat, W. M. Merritt, D. Coffey et al., “Clinical and biological significance of vascular endothelial growth factor in endometrial cancer,” Clinical Cancer Research, vol. 13, no. 24, pp. 7487–7495, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus